Subgroups
Protocols (3)
Outcomes & scoring
gastrointestinal-adverse-event-severity-self-reported1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-clinical-trial-dna-damage-repair-inhibitor-chemotherapy | -15 | 40 | 1 |
oncology-imaging-pet-ct-scan-active-cancer-status1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-clinical-trial-dna-damage-repair-inhibitor-chemotherapy | +90 | 70 | 1 |
oncology-lymph-node-tissue-cancer-status1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-clinical-trial-dna-damage-repair-inhibitor-chemotherapy | +90 | 65 | 1 |
oncology-remission-status-no-evidence-of-disease1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-clinical-trial-dna-damage-repair-inhibitor-chemotherapy | +95 | 70 | 1 |
oncology-treatment-response-benefit-status1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-clinical-trial-antibody-drug-conjugate | 0 | 35 | 1 |
oncology-treatment-response-good-binary1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-clinical-trial-parp-inhibitor | +15 | 30 | 1 |
oncology-tumor-mutation-count-absolute1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-clinical-trial-dna-damage-repair-inhibitor-chemotherapy | +95 | 70 | 1 |
Path: therapy › clinical